Literature DB >> 12796538

Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1.

P Leuraud1, L Aguirre-Cruz, K Hoang-Xuan, E Crinière, M-L Tanguy, J-L Golmard, M Kujas, J-Y Delattre, M Sanson.   

Abstract

An inhibitor of telomerase activity maps to chromosome 10p15.1. A series of 51 high-grade gliomas was analyzed for loss of heterozygosity (LOH) on chromosome 10 and for telomerase activity. In univariate analysis, LOH10p (59%) and LOH10q (61%) were associated with telomerase activity (55%; p < 0.0001 and p = 0.0006). In multivariate analysis, only LOH10p remained statistically related to telomerase activity, suggesting that the telomerase repressor gene located on 10p15.1 is inactivated in high-grade gliomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796538     DOI: 10.1212/01.wnl.0000065894.89082.5e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Integrated genomic analysis for prediction of survival for patients with liver cancer using The Cancer Genome Atlas.

Authors:  Yan-Zhou Song; Xu Li; Wei Li; Zhong Wang; Kai Li; Fang-Liang Xie; Feng Zhang
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

2.  Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.

Authors:  Anna Luisa Di Stefano; Victor Enciso-Mora; Yannick Marie; Virginie Desestret; Marianne Labussière; Blandine Boisselier; Karima Mokhtari; Ahmed Idbaih; Khe Hoang-Xuan; Jean-Yves Delattre; Richard S Houlston; Marc Sanson
Journal:  Neuro Oncol       Date:  2012-11-16       Impact factor: 12.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.